Vivakor gets 180-day Nasdaq extension to March 2026 to meet $1 bid price; reverse split authorized

Vivakor, Inc.

Nasdaq granted 180-day extension until March 16, 2026, to regain minimum $1 bid price compliance.
Company missed initial compliance deadline of Sept 15, 2025; qualifies for additional period.
To cure, stock must close at $1+ for 10 consecutive business days within extension period.
All eight stockholder proposals passed at Sept 11 annual meeting, including reverse stock split authorization.
Stock continues trading on Nasdaq under VIVK; no immediate delisting effect.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.